An important long-term goal in the development of strategies to treat complications associated with diabetes such as, cerebrovascular disease and stroke, is to understand the mechanisms that regulate the structure of cerebral blood vessels;a process termed """"""""cerebrovascular remodeling."""""""" Endothelin-1 (ET-1), a mitogen, is chronically elevated in diabetes. While it is known that ETA receptor activation causes vasoconstriction and VSMC growth, and that the relative ratio of ET receptors (density of ETA and ETB on VSMCs to ETB on endothelial cells) dictates the contractile effects of ET-1;the importance of endothelial ETB receptors in modulating cell growth and vascular structure, and the temporal changes that occur in ET receptor ratios in the cerebral vasculature during diabetes progression are unclear. Diabetic conditions such as elevated glucose and insulin also stimulate expression and activity of matrix metalloproteinases (MMPs), a family of proteases that are critical for vascular remodeling. However, the potential role of ET-1 in regulation of high glucose-stimulated MMP activity, and especially to cerebrovascular remodeling in Type 2 diabetes is unknown. Our central hypothesis is that diabetes-induced changes in the ET system promote hypertrophic remodeling of cerebral microvessels via MMP-mediated activation of cell surface-bound growth signals. To better understand the mechanisms by which diabetes influences cerebrovascular remodeling, Specific Aims will test the subhypotheses that: 1) diabetes stimulates the cerebral microvascular ET system by inducing ET-1 synthesis and increasing the ETA/ETB receptor ratio via down-regulation of vasculoprotective endothelial ETB receptors. Our working model is that endothelial ETB receptors are vasculoprotective and that pharmacological blockade, genetic inhibition and/or diabetes-induced down-regulation of this receptor subtype exacerbates cerebrovascular remodeling in Goto-Kakizaki (GK) rats, a model of Type 2 diabetes. 2) ET-1-mediated stimulation of MMP activity and sequential transactivation of membrane-bound growth factors causes hypertrophic remodeling of cerebral microvessels in diabetes. Our working model is that ET-1, through stimulation of MMP expression and activity, disrupts the integrity of vascular structures to facilitate VSMC proliferation, and enhances epidermal growth factor receptor (EGFR) transactivation, leading to pathological remodeling in the cerebrovasculature in diabetes. Collectively, these studies will contribute to our understanding of the pathophysiological basis of cerebrovascular complications associated with diabetes and development of cerebrovascular protection strategies to retard the progression, delay the onset and even possibly prevent cerebrovascular disease and stroke in diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK074385-05S1
Application #
7920643
Study Section
Clinical Neuroscience and Disease Study Section (CND)
Program Officer
Jones, Teresa L Z
Project Start
2005-09-01
Project End
2010-06-30
Budget Start
2009-09-20
Budget End
2010-06-30
Support Year
5
Fiscal Year
2009
Total Cost
$66,390
Indirect Cost
Name
Georgia Regents University
Department
Physiology
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Abdelsaid, Mohammed; Coucha, Maha; Ergul, Adviye (2014) Cerebrovasculoprotective effects of azilsartan medoxomil in diabetes. Transl Res 164:424-32
Ergul, Adviye; Alhusban, Ahmed; Fagan, Susan C (2012) Angiogenesis: a harmonized target for recovery after stroke. Stroke 43:2270-4
Kelly-Cobbs, A; Elgebaly, M M; Li, W et al. (2011) Pressure-independent cerebrovascular remodelling and changes in myogenic reactivity in diabetic Goto-Kakizaki rat in response to glycaemic control. Acta Physiol (Oxf) 203:245-51
Guan, Weihua; Somanath, Payaningal R; Kozak, Anna et al. (2011) Vascular protection by angiotensin receptor antagonism involves differential VEGF expression in both hemispheres after experimental stroke. PLoS One 6:e24551
Li, Weiguo; Sachidanandam, Kamakshi; Ergul, Adviye (2011) Comparison of selective versus dual endothelin receptor antagonism on cerebrovascular dysfunction in diabetes. Neurol Res 33:185-91
Rigsby, Christine S; Ergul, Adviye; Portik Dobos, Vera et al. (2011) Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension. Am J Hypertens 24:708-15
Elgebaly, Mostafa M; Ogbi, Safia; Li, Weiguo et al. (2011) Neurovascular injury in acute hyperglycemia and diabetes: A comparative analysis in experimental stroke. Transl Stroke Res 2:391-8
Kelly-Cobbs, Aisha I; Harris, Alex K; Elgebaly, Mostafa M et al. (2011) Endothelial endothelin B receptor-mediated prevention of cerebrovascular remodeling is attenuated in diabetes because of up-regulation of smooth muscle endothelin receptors. J Pharmacol Exp Ther 337:9-15
Sachidanandam, Kamakshi; Portik-Dobos, Vera; Kelly-Cobbs, Aisha I et al. (2010) Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes. Can J Physiol Pharmacol 88:616-21
Li, Weiguo; Prakash, Roshini; Kelly-Cobbs, Aisha I et al. (2010) Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia. Diabetes 59:228-35

Showing the most recent 10 out of 29 publications